Literature DB >> 19117339

A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations.

Akatsuki Kubota1, Ayumi Hida, Yaeko Ichikawa, Yoshio Momose, Jun Goto, Yukifusa Igeta, Hideji Hashida, Kunihiro Yoshida, Syu-Ichi Ikeda, Ichiro Kanazawa, Shoji Tsuji.   

Abstract

Neuroferritinopathy is a hereditary neurodegenerative disorder caused by mutations in the ferritin light chain gene (FTL1). The cardinal features are progressive movement disturbance, hypoferritinemia, and iron deposition in the brain. To date, five mutations have been described in Caucasian and Japanese families, but the genotype-phenotype correlations remain to be established. We identified a novel FTL1 mutation (exon 4, c.641/642, 4-nucletotide duplication) in a Japanese family and compared the clinical traits with those previously reported. All mutations but one are insertions in exon 4, resulting in frameshifts. Clinical features are similar among patients with the same mutations. Middle-age onset chorea is common in patients with insertions in the 5' portion of exon 4 including our cases, whereas patients with insertions in the 3' portion of exon 4 develop early-onset tremor, suggesting genotype-phenotype correlations. In this family, male predominance and normal serum ferritin levels are characteristic. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117339     DOI: 10.1002/mds.22435

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

1.  Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro.

Authors:  Erin K Stachowski; Robert Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2011-08-11       Impact factor: 3.575

Review 2.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

3.  A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.

Authors:  Martin A Baraibar; Ana G Barbeito; Barry B Muhoberac; Ruben Vidal
Journal:  Free Radic Biol Med       Date:  2012-02-17       Impact factor: 7.376

Review 4.  Pathogenic mechanism and modeling of neuroferritinopathy.

Authors:  Anna Cozzi; Paolo Santambrogio; Maddalena Ripamonti; Ermanna Rovida; Sonia Levi
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

5.  Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population.

Authors:  Susanne A Schneider; Giovanna Zorzi; Nardo Nardocci
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

6.  Mutant L-chain ferritins that cause neuroferritinopathy alter ferritin functionality and iron permeability.

Authors:  Justin R McNally; Matthew R Mehlenbacher; Sara Luscieti; Gideon L Smith; Aliaksandra A Reutovich; Poli Maura; Paolo Arosio; Fadi Bou-Abdallah
Journal:  Metallomics       Date:  2019-10-16       Impact factor: 4.526

7.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

8.  Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration.

Authors:  Martin A Baraibar; Barry B Muhoberac; Holly J Garringer; Thomas D Hurley; Ruben Vidal
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

Review 9.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

Review 10.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.